Cash

£96K

-91.3% vs 2021

Net assets

-£2M

-252.3% vs 2021

Employees

22

-26.7% vs 2021

Profit before tax

Period ending 2022-12-31

Profile

Company number
07400167
Status
Active
Incorporation
2010-10-07
Last accounts made up
2024-12-31
Account category
FULL
Primary SIC
62090
Hubs
UK AI & Enterprise SaaS

Net assets

6-year trend · vs UK AI & Enterprise SaaS median

£0£1m£2m201920192020202020212022
TICTRAC LIMITED

Accounts

6-year trend · latest 2022-12-31

Metric Trend 2019-01-012019-12-312020-01-012020-12-312021-12-312022-12-31
Turnover
Operating profit
Profit before tax
Net profit -£1,752,284-£3,769,823
Cash £80,842£1,107,399£96,327
Total assets less current liabilities -£7,565,994£1,500,040-£2,268,860
Net assets -£7,571,764£1,493,755-£2,274,425
Equity -£5,689,489-£7,571,764£4,093,167£1,493,755-£2,274,425
Average employees 223022
Wages

Values shown as filed in iXBRL accounts. indicates the figure was not present in the extracted filing (either not filed under that concept or absent from the period). About these numbers

Audit & accounting basis

From AI-extracted PDF accounts

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Grant Thornton UK LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The company made a profit before tax for the year ended 31 December 2024 of £3,501,063 (2023: profit of £4,033,963) with cash of £546,487 (2023: £209,803) at the year end. Dialogue Health Technologies Inc. ("the immediate parent") is the immediate parent company of Tictrac Limited and has issued a letter of financial support to Tictrac Limited for the 12 months after the approval of the financial statements. The immediate parent, Dialogue Health Technologies Inc, has confirmed that it will continue to financially support the company for at least 12 months, from the date of approval of the statutory financial statements for the year ended 31 December 2024 to enable it to meet its liabilities as they fall due. The company has demonstrated its ability to meet all of its obligations at the Statement of Financial Position date, even without considering the receivable from Dialogue Health Technologies Inc. By including the receivable from Dialogue Health Technologies Inc, the company gains additional resources that will allow it to operate for the next 12 months. Additionally, the immediate parent has confirmed its capacity to provide financial support if required. This assurance takes into account potential scenarios where the company might face financial difficulties and require additional funding to continue operations. Therefore, the directors continue to adopt the going concern basis of preparation.”

Significant events

Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers

People

3 active · 14 resigned

Name Role Appointed Born Nationality
BACKHOUSE, Christopher Mark Director 2024-11-29 Aug 1957 British
MANSURI, Navaid Director 2022-04-30 Nov 1972 Canadian
MINER, Richard Director 2024-11-29 Mar 1960 British
Show 14 resigned officers
Name Role Appointed Resigned
BLINDER ACENAL, Luis Martin Secretary 2010-10-07 2023-09-01
CC SECRETARIES LIMITED Corporate Secretary 2014-06-10 2014-06-10
CC SECRETARIES LIMITED Corporate Secretary 2012-12-21 2025-09-19
BLINDER ACENAL, Luis Martin Director 2010-10-07 2023-09-01
DELISLE, Nathalie Director 2022-04-30 2023-03-22
DOUMENG, Jean-Philippe Director 2015-05-21 2016-11-20
HALL II, James Larry Director 2017-05-16 2019-11-05
HAUPT, Ludwig Michael Director 2011-12-12 2022-04-30
HEYWOOD JONES, Benjamin John Director 2023-08-30 2024-01-29
MACCARTHY, Oliver James Director 2011-07-12 2022-04-30
NAOURI, Gabriel Director 2012-08-24 2022-04-30
NOBLE, Mark Andrew Director 2019-06-01 2022-04-30
POPE, Edward Robert Director 2017-02-21 2019-05-20
WEST, Alexander Rupert Director 2020-03-23 2022-04-30

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Mr Luis Martin Blinder Acenal Individual Shares 25–50%, Voting 25–50% 2016-04-06 Ceased 2020-03-23
Mr Oliver James Maccarthy Individual Shares 25–50%, Voting 25–50% 2016-04-06 Ceased 2020-03-23

Filing timeline

Last 20 of 117 total filings

Date Type Category Description
2025-10-04 AA accounts accounts with accounts type full
2025-09-24 CH01 officers change person director company with change date
2025-09-19 CH01 officers change person director company with change date
2025-09-19 CH01 officers change person director company with change date
2025-09-19 TM02 officers termination secretary company with name termination date
2025-09-19 AD01 address change registered office address company with date old address new address
2025-07-17 CS01 confirmation-statement confirmation statement with no updates
2024-12-17 AA accounts accounts with accounts type full
2024-11-29 AP01 officers appoint person director company with name date
2024-11-29 AP01 officers appoint person director company with name date
2024-07-15 CS01 confirmation-statement confirmation statement with no updates
2024-07-15 CH01 officers change person director company with change date
2024-03-19 AA accounts accounts with accounts type group
2024-03-16 DISS40 gazette gazette filings brought up to date
2024-03-12 GAZ1 gazette gazette notice compulsory
2024-01-29 TM01 officers termination director company with name termination date
2023-09-12 AP01 officers appoint person director company with name date
2023-09-04 TM02 officers termination secretary company with name termination date
2023-09-04 TM01 officers termination director company with name termination date
2023-07-25 CS01 confirmation-statement confirmation statement with no updates

Credit score

Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage

Credit score requires EBIT (operating profit / PBT) — not present in the latest extracted accounts.

Activity Score

Filings velocity, capital events, officer churn, accounts trajectory

Activity Score not yet computed for this company.

Official Companies House page